- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07718828
Laparoscopic Nissen Versus Toupet Fundoplication for Hiatal Hernia.
17. juli 2026 oppdatert av: Katya Todorova, Sofia Med Hospital
Laparoscopic Nissen Versus Toupet Fundoplication for Gastroesophageal Reflux Management in Patients With Hiatal Hernia: A Patient- and Assessor-Blinded Randomized Controlled Trial
This randomized controlled trial compares laparoscopic Nissen fundoplication and laparoscopic Toupet fundoplication in patients undergoing surgical treatment for hiatal hernia associated with gastroesophageal reflux disease.
Participants will be randomly assigned to one of two surgical groups.
The study will evaluate postoperative pain, health-related quality of life, hospital stay, recurrence of reflux symptoms, gas-bloat symptoms, operative time, fundoplication time, and postoperative complications.
Studieoversikt
Status
Rekruttering
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Antatt)
200
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Katya T. Todorova, PhD
- Telefonnummer: +359884744833
- E-post: katya.todorowa@gmail.com
Studer Kontakt Backup
- Navn: Teodor D. Atanasov, Assoc. Prof.
- Telefonnummer: +359899802612
- E-post: teodor.atanassov@gmail.com
Studiesteder
-
-
Sofia-Grad
-
Sofia, Sofia-Grad, Bulgaria, 1517
- Rekruttering
- UMHAT Sofiamed
-
Ta kontakt med:
- Katya T. Todorova, PhD
- Telefonnummer: 0884744833
- E-post: katya.todorowa@gmail.com
-
Ta kontakt med:
- E-post: teodor.atanassov@gmail.com
-
Hovedetterforsker:
- Teodor D Atanasov, Assoc. prof.
-
Hovedetterforsker:
- Katya T Todorova
-
Underetterforsker:
- Alexander I Tsvetanov
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- Patients aged 18 to 90 years
- Patients diagnosed with primary hiatal hernia by fibrogastroscopy and/or barium swallow examination
- Patients with symptoms of gastroesophageal reflux disease
- Patients scheduled for elective laparoscopic hiatal hernia repair with fundoplication
- Patients able to provide informed consent
Exclusion Criteria:
Patients younger than 18 years or older than 90 years Patients with recurrent hiatal hernia Patients who are not suitable for general anesthesia Patients who prefer a surgical approach other than laparoscopic surgery Patients who are unable or unwilling to provide informed consent
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Nissen fundoplication
Participants assigned to this arm will undergo laparoscopic hiatal hernia repair with Nissen fundoplication.
The procedure includes a complete 360° fundoplication performed as part of standard laparoscopic antireflux surgery.
|
The procedure includes a complete 360° fundoplication performed as part of standard laparoscopic antireflux surgery.
|
|
Aktiv komparator: Toupet Fundoplication
Participants assigned to this arm will undergo laparoscopic hiatal hernia repair with Toupet fundoplication.
The procedure includes a partial posterior 270° fundoplication performed as part of standard laparoscopic antireflux surgery.
|
The procedure includes a partial posterior 270° fundoplication performed as part of standard laparoscopic antireflux surgery.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Postoperative pain score at 24 hours
Tidsramme: 24 hours after surgery
|
Postoperative pain will be assessed 24 hours after surgery using the Visual Analog Scale.
The score will be used to compare early postoperative pain between participants undergoing laparoscopic Nissen fundoplication and those undergoing laparoscopic Toupet fundoplication.
|
24 hours after surgery
|
|
Postoperative Pain Score at 7 Days
Tidsramme: 7 days after surgery
|
Postoperative pain will be assessed 7 days after surgery using the Visual Analog Scale.
The score will be used to evaluate and compare short-term postoperative pain between the two intervention groups.
|
7 days after surgery
|
|
Change in Health-Related Quality of Life After Surgery
Tidsramme: Preoperatively, 1 week, 4 weeks
|
Health-related quality of life will be assessed using the GERD-Health Related Quality of Life questionnaire.
Preoperative scores will be compared with postoperative scores in order to evaluate changes in reflux-related symptoms and quality of life after laparoscopic Nissen or Toupet fundoplication.
|
Preoperatively, 1 week, 4 weeks
|
|
Postoperative Hospital Stay
Tidsramme: From the day of surgery until hospital discharge - up to 30days
|
Postoperative hospital stay will be measured as the number of days from the day of surgery until hospital discharge.
The duration of hospital stay will be compared between the Nissen and Toupet fundoplication groups.
|
From the day of surgery until hospital discharge - up to 30days
|
|
Recurrence of Gastroesophageal Reflux Symptoms
Tidsramme: 4 weeks and 1 year after surgery
|
Recurrence of gastroesophageal reflux symptoms will be assessed during postoperative follow-up.
The presence or absence of recurrent reflux symptoms will be recorded and compared between the two intervention groups.
|
4 weeks and 1 year after surgery
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Operative Timе
Tidsramme: Intraoperative
|
Operative time will be measured in minutes from the beginning to the end of the laparoscopic surgical procedure.
Total operative time will be compared between participants undergoing Nissen fundoplication and those undergoing Toupet fundoplication.
|
Intraoperative
|
|
Fundoplication Time
Tidsramme: Intraoperative
|
Fundoplication time will be measured in minutes as the time required to perform the fundoplication component of the procedure.
This measure will be used to compare the technical duration of Nissen and Toupet fundoplication.
|
Intraoperative
|
|
Gas-Bloat Symptoms
Tidsramme: 3 days; 1 week
|
Postoperative gas-bloat symptoms will be assessed during follow-up.
The presence or absence of symptoms such as bloating, inability to belch, or increased abdominal gas-related discomfort will be recorded and compared between the two groups.
|
3 days; 1 week
|
|
Postoperative Complications
Tidsramme: Up to 30 days after surgery
|
Postoperative complications will be recorded according to type and frequency.
The number and nature of postoperative complications will be compared between the Nissen and Toupet fundoplication groups.
|
Up to 30 days after surgery
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
29. mai 2023
Primær fullføring (Antatt)
30. juli 2026
Studiet fullført (Antatt)
31. januar 2027
Datoer for studieregistrering
Først innsendt
19. juni 2026
Først innsendt som oppfylte QC-kriteriene
17. juli 2026
Først lagt ut (Faktiske)
22. juli 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
22. juli 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
17. juli 2026
Sist bekreftet
1. juli 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 25/2023
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .